Trastuzumab Deruxtecan Plus Pertuzumab Improves Progression-Free Survival in Patients With HER2+ Metastatic Breast Cancer
Analysis Reveals Polypharmacy Challenges in Patients With Cancer
FDA Grants Breakthrough Therapy Designation to AMT-130 to Treat Huntington Disease
FAERS Analysis Provides New Insights on Cefiderocol Adverse Effects